Literature DB >> 7025066

The effect of intravenous prostacyclin on resting pains and healing of ischaemic ulcers in peripheral artery disease.

A G Olsson, E Nilsson.   

Abstract

Prostacyclin (PGI2) was given intravenously in doses of 1 to 5 ng/kg/min to eight consecutive patients with end stage peripheral arteriosclerosis and ischaemic ulcers. Seven patients had intense ischaemic pains. Complete or partial healing of ulcers were seen in six cases (complete in three). In those whose ulcers healed (complete or partially) relief of ulcer pain was remarkable. Acute studies of the effect of prostacyclin on skin temperature of ischaemic areas showed no correlation with clinical effects. Seven patients had more or less pronounced subjective side effects, most often flushing, nausea, headache and uneasiness. As we previously have seen equally good healing and pain relieving effects by the administration of prostaglandin E1 without these side effects the latter compound is so far preferred in the treatment of severe peripheral artery disease. Controlled studies of the effect are needed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7025066     DOI: 10.1016/0161-4630(81)90064-1

Source DB:  PubMed          Journal:  Prostaglandins Med        ISSN: 0161-4630


  5 in total

1.  Dazoxiben: a pharmacological tool or clinical candidate?

Authors:  H M Tyler
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

2.  Development of optimal infusion regimens for epoprostenol using radio labelled platelet uptake over atherosclerotic lesions in man.

Authors:  H Sinzinger; P Fitscha; J Kaliman; K Silberbauer; J O'Grady
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

3.  Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man.

Authors:  H Pickles; J O'Grady
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

4.  Stability of prostacyclin analogues: an unusual lack of reactivity in acid-catalyzed alkene hydration.

Authors:  A Magill; C O'Yang; M F Powell
Journal:  Pharm Res       Date:  1988-04       Impact factor: 4.200

5.  Prolonged infusion of prostacyclin in patients with advanced stages of peripheral vascular disease: a placebo-controlled cross-over study.

Authors:  V Hossmann; H Auel; W Rücker; K Schrör
Journal:  Klin Wochenschr       Date:  1984-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.